Ikarian Capital »

Surrozen shares owned by Ikarian Capital

Quarter-by-quarter ownership of Surrozen (SRZN) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Surrozen

Tip: Access up to 7 years of quarterly data

All positions including Surrozen held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Surrozen by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.5M 66k 22.60

More positions owned by Ikarian Capital

Cidara Therapeutics Com New (CDTX)
Spdr Series Trust State Street Spd Put Option (XBI)
Amgen (AMGN)
Terns Pharmaceuticals (TERN)
Abivax Sa Sponsored Ads (ABVX)
Harrow Health (HROW)
Rapt Therapeutics Com New (RAPT)
Cytokinetics Com New (CYTK)
Jazz Pharmaceuticals Call Call Option
Soleno Therapeutics (SLNO)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Maze Therapeatics (MAZE)
Omeros Corporation Call Option (OMER)
Praxis Precision Medicines I Com New (PRAX)
Olema Pharmaceuticals (OLMA)

View all positions for Ikarian Capital

Top funds holding Surrozen

VR Adviser
Stempoint Capital
RA Capital Management
Braidwell
Boxer Capital Management
5AM Venture Management
Vanguard Group
Vivo Capital
Woodline Partners
Nantahala Capital Management
Longwood Capital Partners
Silverarc Capital Management
Regents of the University of California
Stonepine Capital Management
Millennium Management

View all funds holding Surrozen